XM tillhandahåller inte tjänster till personer bosatta i USA.
A
A

Akamai


Nyheter

U.S. Apollo, Blackstone, Hershey

U.S. RESEARCH ROUNDUP- Apollo, Blackstone, Hershey Aug 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Apollo, Blackstone and Hershey, on Tuesday. HIGHLIGHTS * Apollo APO.N : Jefferies cuts target price to $114 from $129 * Blackstone BX.N : Jefferies raises target price to $147 from $138 * Hershey Co HSY.N : Goldman Sachs initiates coverage with sell rating * Palomar Holdings Inc PLMR.O : KBW raises target price to
A
A
A
A

U.S. STOCKS Revance Therapeutics, Insulet, StepStone

BUZZ-U.S. STOCKS ON THE MOVE-Revance Therapeutics, Insulet, StepStone Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes swung between gains and losses on the last day of a tumultuous week that rocked the global markets as the low-yielding yen surged and fears of a recession gripped the world's biggest economy.
A
B
B
E
I
N
L
T
U
U

U.S. STOCKS Synchrony, Grindr, Blend Labs

BUZZ-U.S. STOCKS ON THE MOVE-Synchrony, Grindr, Blend Labs Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were set to clock weekly losses on Friday, capping off a tumultuous week where global markets were rattled by a sharp appreciation in the low-yielding yen and fears of a recession in the world's biggest economy.
A
B
E
I
N
L
T
U
U

U.S. STOCKS Doximity, Expedia, Nikola

BUZZ-U.S. STOCKS ON THE MOVE-Doximity, Expedia, Nikola Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes opened lower on the last day of a turbulent week, while Federal Reserve officials' dovish signals following a report of a resilient labor market kept losses in check.
A
B
E
I
N
T
U
U

Akamai jumps on Q2 results, upbeat forecast

BUZZ-Akamai jumps on Q2 results, upbeat forecast ** Akamai Technologies AKAM.O shares up 7.4% to $98.30 premarket after strong results and forecast ** AKAM Q2 revenue up 5% to $980 mln, above expectations, gaining from rise in internet traffic ** Akamai offers a network of servers and tools to deliver web content over the internet, along with cyber
A

U.S. Duolingo, Nova, Universal Health Services

U.S. RESEARCH ROUNDUP-Duolingo, Nova, Universal Health Services Aug 9 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Duolingo, Nova and Universal Health Services, on Friday. HIGHLIGHTS * Duolingo Inc DUOL.O : Goldman Sachs raises to neutral from sell * Eventbrite Inc EB.N : Piper Sandler cuts to neutral from overweight * HCA Healthcare Inc HCA.N : JP Morgan raises target price to $379 from $332 * Nova Ltd NVMI.O : E
A
A

Akamai forecasts quarterly revenue above estimates on cybersecurity demand

Akamai forecasts quarterly revenue above estimates on cybersecurity demand Aug 8 (Reuters) - Akamai Technologies AKAM.O forecast third-quarter revenue and profit above estimates on Thursday, betting on strong demand for its cybersecurity services as businesses spend heavily on safeguarding their systems against rising threats from hackers. Shares of the Cambridge, Massachusetts-based company rose 4% in extended trading.
A
E
E

Akamai Technologies Inc reports results for the quarter ended in June - Earnings Summary

Akamai Technologies Inc reports results for the quarter ended in June - Earnings Summary Akamai Technologies Inc AKAM.OQ reported quarterly adjusted earnings of $1.58​​ per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of $1.49. The mean expectation of twenty analysts for the quarter was for earnings of $1.53 per share.
A

Akamai Q2 Adjusted EPS USD 1.58 Vs. IBES Estimate USD 1.53

BRIEF-Akamai Q2 Adjusted EPS USD 1.58 Vs. IBES Estimate USD 1.53 Aug 08 (Reuters) - Akamai Q2 net income USD 131.688 million. Q2 revenue USD 979.58 million vs. IBES estimate USD 977.2 million Q2 EPS USD 0.86 Q2 adjusted EBITDA USD 409 million vs. IBES estimate USD 405.9 million
A

Markets stay bumpy awaiting jobs reality check

MORNING BID AMERICAS-Markets stay bumpy awaiting jobs reality check A look at the day ahead in U.S. and global markets from Mike Dolan Seeking some calm, markets remain edgy following the volatility jolt of the past week and traders now seek some re-assurance the real economy has not shifted underneath them. Volatility spikes like the one seen on Monday rarely disappear instantly and, with the VIX 'fear gauge' .VIX still above historical averages of about 20 , some turbulence remains.
A
E
G
N
N
U
T
J
U
U
U
F
M

Akamai Technologies Inc <AKAM.OQ> expected to post earnings of $1.53 a share - Earnings Preview

Akamai Technologies Inc expected to post earnings of $1.53 a share - Earnings Preview Akamai Technologies Inc AKAM.OQ AKAM.O is expected to show a rise in quarterly revenue when it reports results on August 8 for the period ending June 30 2024 The Cambridge Massachusetts-based company is expected to report a 4.4% increase in revenue to $977.242 million from $935.72 million a year ago, according to the mean estimate from 19 analysts, based on LSEG data.The company's guidance on May 9 2024, for th
A

U.S. STOCKS Bank of Marin Bancorp, ON Semiconductor, Walt Disney

BUZZ-U.S. STOCKS ON THE MOVE-Bank of Marin Bancorp, ON Semiconductor, Walt Disney Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq and the S&P 500 rose in choppy, range-bound trading on Monday as investors looked forward to a raft of upcoming triggers such as Big Tech earnings, a Federal Reserve policy decision on interest-rate cuts and key labor data.
A
A
A
C
N
T
O
U
U

U.S. STOCKS Ventyx Biosciences, McDonald's, Pinterest

BUZZ-U.S. STOCKS ON THE MOVE-Ventyx Biosciences, McDonald's, Pinterest Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq and the S&P 500 rose on Monday, buoyed by megacap stocks as investors awaited Big Tech results, a Federal Reserve policy decision and crucial labor numbers this week.
A
A
A
N
P
T
O
U
U

Akamai Technologies rises as Guggenheim turns bullish

BUZZ-Akamai Technologies rises as Guggenheim turns bullish ** Akamai Technologies' AKAM.O shares up ~1% at $97.90 early Mon after Guggenheim upgrades to "buy" from "neutral" ** Brokerage sets PT at $128, implying 32% upside to stock's Fri close ** AKAM set up to transform itself to a platform, and can leverage leadership position in content delivery network (CDN) business to deliver security and cloud solutions, Guggenheim analyst team led by John DiFucci said in note ** CDN technology foundatio
A
F
N

Major tech outages in recent years

FACTBOX-Major tech outages in recent years July 19 (Reuters) - A global tech outage was disrupting operations across multiple industries on Friday, with airlines halting flights, some broadcasters off air and services from banking to healthcare hit by system problems. Cybersecurity firm Crowdstrike CRWD.O said it was working with customers impacted by a defect found in a single content update for Microsoft MSFT.O Windows hosts.
A
A
G
M
P
S

U.S. Armada Hoffler Properties, Morphic Holding, Solid Biosciences

U.S. RESEARCH ROUNDUP-Armada Hoffler Properties, Morphic Holding, Solid Biosciences July 15 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Armada Hoffler Properties, Morphic Holding and Solid Biosciences, on Monday. HIGHLIGHTS * Armada Hoffler Properties Inc AHH.N : Jefferies cuts to hold from buy * Morphic Holding Inc MORF.O : Jefferies cuts to hold from buy * Solid Biosciences Inc SLDB.O : JP Morgan raises to over
A
A
C
C
H
J
A
E
P
U
W
A
E
H
M

U.S. Acelyrin, Blue Owl Capital, Malibu Boats

U.S. RESEARCH ROUNDUP-Acelyrin, Blue Owl Capital, Malibu Boats July 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Acelyrin, Blue Owl Capital and Malibu Boats, on Monday. HIGHLIGHTS * Acelyrin Inc SLRN.O : Wells Fargo raises to overweight from equal-weight * Blue Owl Capital Inc OWL.N : TD Cowen cuts to hold from buy * J B Hunt Transport Services Inc JBHT.O : Stephens initiates with overweight rating * Malibu Boat
A
A
C
C
G
G
U
G
A
A
A
A
R



Villkor

Populära tillgångar

Ansvarsfriskrivning: XM Group-enheter tillhandahåller sin tjänst enbart för exekvering och tillgången till vår onlinehandelsplattform, som innebär att en person kan se och/eller använda tillgängligt innehåll på eller via webbplatsen, påverkar eller utökar inte detta, vilket inte heller varit avsikten. Denna tillgång och användning omfattas alltid av i) villkor, ii) riskvarningar och iii) fullständig ansvarsfriskrivning. Detta innehåll tillhandahålls därför uteslutande som allmän information. Var framför allt medveten om att innehållet på vår onlinehandelsplattform varken utgör en uppmaning eller ett erbjudande om att ingå några transaktioner på de finansiella marknaderna. Handel på alla finansiella marknader involverar en betydande risk för ditt kapital.

Allt material som publiceras på denna sida är enbart avsett för utbildnings- eller informationssyften och innehåller inte – och ska inte heller anses innehålla – rådgivning och rekommendationer om finansiella frågor, investeringsskatt eller handel, dokumentation av våra handelskurser eller ett erbjudande om, eller en uppmaning till, en transaktion i finansiella instrument eller oönskade finansiella erbjudanden som är riktade till dig.

Tredjepartsinnehåll, liksom innehåll framtaget av XM såsom synpunkter, nyheter, forskningsrön, analyser, kurser, andra uppgifter eller länkar till tredjepartssajter som återfinns på denna webbplats, tillhandahålls i befintligt skick, som allmän marknadskommentar, och utgör ingen investeringsrådgivning. I den mån som något innehåll tolkas som investeringsforskning måste det noteras och accepteras att innehållet varken har varit avsett som oberoende investeringsforskning eller har utarbetats i enlighet med de rättsliga kraven för att främja ett sådant syfte, och därför är att betrakta som marknadskommunikation enligt tillämpliga lagar och föreskrifter. Se till så att du har läst och förstått vårt meddelande om icke-oberoende investeringsforskning och riskvarning om ovannämnda information, som finns här.

Riskvarning: Ditt kapital riskeras. Hävstångsprodukter passar kanske inte alla. Se vår riskinformation.